F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Chronic hepatitis B

Page 1 of 4 ( 189 items )
<<
1
2
3
4
>>

1	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 22 \| Download: 43
2	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 29 \| Download: 58
3	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 23 \| Download: 41
4	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 51 \| Download: 159
5	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 36 \| Download: 144
6	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 51 \| Download: 185
7	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 50 \| Download: 271
8	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 35 \| Download: 128
9	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 57 \| Download: 197
10	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 95 \| Download: 334
11	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 79 \| Download: 368
12	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 135 \| Download: 573
13	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 135 \| Download: 564
14	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 113 \| Download: 496
15	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 296 \| Download: 628
16	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 308 \| Download: 740
17	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 428 \| Download: 610
18	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 352 \| Download: 552
19	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 216 \| Download: 463
20	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 561 \| Download: 577
21	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 186 \| Download: 563
22	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 416 \| Download: 537
23	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 278 \| Download: 409
24	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 299 \| Download: 699
25	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 308 \| Download: 1038
26	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 218 \| Download: 973
27	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 370 \| Download: 1151
28	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 322 \| Download: 968
29	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 283 \| Download: 935
30	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 275 \| Download: 688
31	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 111 \| Download: 550
32	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 327 \| Download: 906
33	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 382 \| Download: 1087
34	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 376 \| Download: 1357
35	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 189 \| Download: 1214
36	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 304 \| Download: 1046
37	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 356 \| Download: 952
38	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 353 \| Download: 854
39	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 376 \| Download: 1171
40	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 446 \| Download: 1678
41	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 304 \| Download: 818
42	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 408 \| Download: 839
43	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 370 \| Download: 1047
44	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 238 \| Download: 1404
45	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 402 \| Download: 1501
46	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 515 \| Download: 1525
47	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 491 \| Download: 1381
48	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 559 \| Download: 1829
49	Antiviral treatment standards for hepatitis B: An urgent need for expansion 1/26/2024 7:56:29 AM \| Browse: 605 \| Download: 1443
50	Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir 12/6/2023 8:08:49 AM \| Browse: 572 \| Download: 1651

Page 1 of 4 ( 189 items )
<<
1
2
3
4
>>

1	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 22 \| Download: 43
2	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 29 \| Download: 58
3	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 23 \| Download: 41
4	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 51 \| Download: 159
5	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 36 \| Download: 144
6	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 51 \| Download: 185
7	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 50 \| Download: 271
8	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 35 \| Download: 128
9	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 57 \| Download: 197
10	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 95 \| Download: 334
11	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 79 \| Download: 368
12	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 135 \| Download: 573
13	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 135 \| Download: 564
14	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 113 \| Download: 496
15	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 296 \| Download: 628
16	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 308 \| Download: 740
17	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 428 \| Download: 610
18	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 352 \| Download: 552
19	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 216 \| Download: 463
20	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 561 \| Download: 577
21	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 186 \| Download: 563
22	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 416 \| Download: 537
23	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 278 \| Download: 409
24	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 299 \| Download: 699
25	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 308 \| Download: 1038
26	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 218 \| Download: 973
27	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 370 \| Download: 1151
28	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 322 \| Download: 968
29	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 283 \| Download: 935
30	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 275 \| Download: 688
31	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 111 \| Download: 550
32	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 327 \| Download: 906
33	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 382 \| Download: 1087
34	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 376 \| Download: 1357
35	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 189 \| Download: 1214
36	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 304 \| Download: 1046
37	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 356 \| Download: 952
38	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 353 \| Download: 854
39	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 376 \| Download: 1171
40	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 446 \| Download: 1678
41	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 304 \| Download: 818
42	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 408 \| Download: 839
43	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 370 \| Download: 1047
44	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 238 \| Download: 1404
45	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 402 \| Download: 1501
46	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 515 \| Download: 1525
47	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 491 \| Download: 1381
48	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 559 \| Download: 1829
49	Antiviral treatment standards for hepatitis B: An urgent need for expansion 1/26/2024 7:56:29 AM \| Browse: 605 \| Download: 1443
50	Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir 12/6/2023 8:08:49 AM \| Browse: 572 \| Download: 1651